Approval · Notice of Compliance 18548 · 2016
IBUPROFEN CAPLETS: Notice of Compliance 18548
Issued October 4, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18548
- Date
- October 4, 2016
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Canadian reference product
- ADVIL ADULT (Wyeth Consumer Healthcare Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN CAPLETS | 02394731 | Approved |
| IBUPROFEN EXTRA STRENGTH CAPLETS | 02394758 | Approved |
| IBUPROFEN TABLETS | 02394715 | Approved |